I asked about plans to develop the PAD. Here's the response from Bernie:
Inovio’s primary core focus is on our immunotherapies and vaccines, and that is where we’re directing our resources.
However, the researchers’ do intend to advance the preclinical research.
Senior Director, Corporate Communications
Sentiment: Strong Buy
Please define PAD, and advance the preclinical research on what? Thanks.
Review the July 18 press release.